Sodium alendronate, which belongs to the group of biphosphonates, has been released as a new drinking solution on the French market. The drinkable solution is easy to take and is quickly absorbed. The active substance is indicated for postmenopausal osteoporosis and reduces the risk of vertebral and hip fractures.